Direct Contraction Force Measurements of Engineered Cardiac Tissue Constructs With Inotropic Drug Exposure

Maria Koivisto, Milad Mosallaei, Tarja Toimela, Sampo Tuukkanen, Tuula Heinonen

    Research output: Contribution to journalArticleScientificpeer-review

    7 Downloads (Pure)

    Abstract

    Contractility is one of the most crucial functions of the heart because it is directly related to the maintenance of blood perfusion throughout the body. Both increase and decrease in contractility may cause fatal consequences. Therefore, drug discovery would benefit greatly from reliable testing of candidate molecule effects on contractility capacity. In this study, we further developed a dual-axis piezoelectric force sensor together with our human cell–based vascularized cardiac tissue constructs for cardiac contraction force measurements. The capability to detect drug-induced inotropic effects was tested with a set of known positive and negative inotropic compounds of isoprenaline, milrinone, omecamtiv mecarbil, propranolol, or verapamil in different concentrations. Both positive and negative inotropic effects were measurable, showing that our cardiac contraction force measurement system including a piezoelectric cantilever sensor and a human cell–based cardiac tissue constructs has the potential to be used for testing of inotropic drug effects.
    Original languageEnglish
    Article number871569
    Number of pages9
    JournalFRONTIERS IN PHARMACOLOGY
    Volume13
    DOIs
    Publication statusPublished - 3 May 2022
    Publication typeA1 Journal article-refereed

    Publication forum classification

    • Publication forum level 1

    Fingerprint

    Dive into the research topics of 'Direct Contraction Force Measurements of Engineered Cardiac Tissue Constructs With Inotropic Drug Exposure'. Together they form a unique fingerprint.

    Cite this